These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28045339)

  • 1. Imaging, biodistribution and efficacy evaluation of
    Chen LC; Chang YJ; Chen SJ; Lee WC; Chang CH; Lee TW; Shien JH
    Int J Radiat Biol; 2017 May; 93(5):477-486. PubMed ID: 28045339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution, Pharmacokinetics and Efficacy of
    Chen LC; Lee WC; Ho CL; Chang YJ; Chen SJ; Chang CH
    In Vivo; 2018; 32(3):567-573. PubMed ID: 29695562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
    Ni HC; Yu CY; Chen SJ; Chen LC; Lin CH; Lee WC; Chuang CH; Ho CL; Chang CH; Lee TW
    Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
    Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ
    Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
    Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
    Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma.
    Shih YH; Peng CL; Chiang PF; Lin WJ; Luo TY; Shieh MJ
    Int J Nanomedicine; 2015; 10():7443-54. PubMed ID: 26719687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation Efficacy of Rhenium-188-Loaded Micro-particles for Radiotherapy in a Mouse Model of Hepatocellular Carcinoma.
    Shih YH; Peng CL; Weng MF; Chiang PF; Luo TY; Lin XZ
    Mol Pharm; 2019 Mar; 16(3):1083-1091. PubMed ID: 30638389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
    Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
    Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.
    Molina-Trinidad EM; de Murphy CA; Jung-Cook H; Stack EM; Pedraza-Lopez M; Morales-Marquez JL; Serrano GV
    J Pharm Pharmacol; 2010 Apr; 62(4):456-61. PubMed ID: 20604834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
    De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO
    Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
    Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
    Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
    Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
    Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
    Ferro-Flores G; Arteaga de Murphy C
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1389-401. PubMed ID: 18547675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
    Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
    Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
    Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
    Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
    Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.